EDIT
Editas Medicine Inc.
$5.6
Earnings Summary
Revenue | $60.05Mn |
Net Profits | $-18.87Mn |
Net Profit Margins | -31.43% |
Highlights
Editas Medicine Inc.’s revenue jumped 818.74% since last year same period to $60.05Mn in the Q4 2023. On a quarterly growth basis, Editas Medicine Inc. has generated 1025.36% jump in its revenue since last 3-months.
Editas Medicine Inc.’s net profit jumped 65.7% since last year same period to $-18.87Mn in the Q4 2023. On a quarterly growth basis, Editas Medicine Inc. has generated 58.08% jump in its net profits since last 3-months.
Editas Medicine Inc.’s net profit margin jumped 96.27% since last year same period to -31.43% in the Q4 2023. On a quarterly growth basis, Editas Medicine Inc. has generated 96.27% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Editas Medicine Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.67 |
EPS Estimate Current Year | -0.67 |
Highlights
Editas Medicine Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.67 - a -24.07% fall from last quarter’s estimates.
Editas Medicine Inc.’s earning per share (EPS) estimates for the current year stand at -0.67.
Key Ratios
Key ratios of the Editas Medicine Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.23 |
Highlights
Editas Medicine Inc.’s earning per share (EPS) jumped 73.86% since last year same period to -0.23 in the Q4 2023. This indicates that the Editas Medicine Inc. has generated 73.86% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-05 | -0.78 | -0.71 | 8.97% |
2023-08-02 | -0.76 | -0.56 | 26.32% |
2023-11-03 | -0.57 | -0.55 | 3.51% |
2024-02-28 | -0.54 | -0.23 | 57.41% |
₹0 US Stocks a/c Opening Fee